Replies to post #12610 on Ariad Pharmaceuticals Inc fka ARIA

[ariadndndough]

Bth. I respectively disagree. There has been no advancement for
Years. It's not like it will have to compete with much now.
And say what you want about merck. But merck sales will get more
Out of it then most could


Imho

[NP1986]

I don't know what the analysts are predicting, but I don't see ridaforolimus being very successful either. Yes, treatment options for sarcoma are limited, but the efficacy of ridaforolimus wasn't spectacular.

Technically, as a maintenance therapy only patients who have at least stable disease following first line chemotherapy would be eligible for treatment with ridaforolimus. So that narrows an already small patient population.